Development of polylactide and polyethylene vinyl acetate blends for the manufacture of vaginal rings

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 100 B, Issue 4, 2012, Pages 891-895

  Mc Conville, Christopher ^a,b   Major, Ian ^a   Friend, David R ^c   Clark, Meredith R ^c   Woolfson, A David ^a   Malcolm, R Karl ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b CURTIN UNIVERSITY   (Australia)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

HIV microbicides; polyethylene vinyl acetate; polylactide; tenofovir; vaginal rings

Indexed keywords

HYDROPHOBIC POLYMERS; MICROBICIDES; POLY LACTIDE; POLYMER DEGRADATION; RELEASE RATE; REVERSE TRANSCRIPTASES; SILICONE ELASTOMERS; TENOFOVIR; VINYL ACETATES;

BLENDING; FLEXIBLE MANUFACTURING SYSTEMS; SILICONES;

BIODEGRADABLE POLYMERS;

POLYETHYLENE DERIVATIVE; POLYETHYLENE VINYL ACETATE; POLYLACTIDE; TENOFOVIR; UNCLASSIFIED DRUG;

ARTICLE; BIOCOMPATIBILITY; BIODEGRADATION; DRUG RELEASE; IN VITRO STUDY; VAGINA RING;

ADENINE; ANTI-INFECTIVE AGENTS; ANTIVIRAL AGENTS; BIOCOMPATIBLE MATERIALS; BODY FLUIDS; CONTRACEPTIVE DEVICES, FEMALE; DIFFUSION; DRUG DELIVERY SYSTEMS; FEMALE; HIV INFECTIONS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PHOSPHONIC ACIDS; POLYESTERS; POLYMERS; POLYVINYLS; VAGINA;

EID: 84859608691     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31919     Document Type: Article

References (29)

1. Woolfson AD, Elliott GRE, Gilligan CA, Passmore CM,. Design of an intravaginal ring for the controlled delivery of 17beta-estradiol as its 3-acetate ester. J Control Release 1999; 61: 19-328.
2. Malcolm RK,. Vaginal rings for controlled release drug delivery. In, Rathbone MJ, Hadgraft J, Roberts MS, Lane ME, editors. Modified Release Drug Delivery Technology, 2nd ed. New York: Informa Healthcare; 2008. pp 499-510.
3. Brucker C, Karck U, Merkle E,. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring. NuvaRingÂ: Results of clinical experience in Germany. Eur J Contracept Reprod Health Care 2008; 13: 31-38.
4. Woolfson AD, Malcolm RK, Gallagher RJ,. Design of a silicone reservoir intravaginal ring for the delivery of oxybutynin. J Controlled Release 2003; 91: 465-76.
5. Woolfson AD, Malcolm RK, Morrow RJ, Toner CF, McCullagh SD,. Intravaginal ring delivery of the reverse transcriptase inhibitor TMC 120 as an HIV microbicide. Int J Pharm 2006; 325: 82-89.
6. Malcolm RK, Woolfson AD, Morrow RJ, Toner CF, McCullagh SD,. Long-term controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings. J Antimicrob Chemother 2005; 56: 954-956.
7. Karim QA, Karim SSA, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, Kharsany ABM, Sibeko S, Mlisana KP, Omar Z, Gengiah TN, Maarschalk S, Arulappan N, Mlotshwa M, Morris L, Taylor D,. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of hiv infection in women. Science 2010; 329: 1168-1164.
8. Woolfson AD, Malcolm RK, Gallagher R,. Drug delivery by the intravaginal route. Crit Rev Ther Drug Carrier Syst 2000; 17: 509-55.
9. Johnson TJ, Gupta KM, Fabian J, Albright TH, Kiser PF,. Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and Tenofovir. Eur J Pharm Sci 2010; 39: 203-212.
10. Saxena BB, Han YA, Fu D, Rathnam P, Singh M, Laurence J, Lerner S,. Sustained release of microbicides by newly engineered vaginal rings. AIDS 2009; 23: 917-922.
11. Lu Y, Chen SC,. Micro and nano-fabrication of biodegradable polymers for drug delivery. Adv Drug Deliv Rev 2004; 56: 1621-1633.
12. Funke U, Bergthaller W, Lindhauer MG,. Processing and characterization of biodegradable products based on starch. Polym Degrad Stab 1998; 59: 293-296.
13. Widmer MS, Gupta PK, Lu L, Meszlenyi RK, Evans GRD, Brandt K, Savel T, Gurlek A, Patrick CW Jr, Mikos AG,. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 1998; 19: 1945-1955.
14. Gomes ME, Ribeiro AS, Malafaya PB, Reis RL, Cunha AM,. A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: Morphology, mechanical and degradation behaviour. Biomaterials 2001; 22: 883-889.
15. Kotsar A, Nieminen R, Isotalo T, Mikkonen J, Uurto I, Kellomaki M, Talja M, Moilanen E, Tammela TLJ,. Biocompatibility of new drug-eluting biodegradable urethral stent materials. Urology 2010; 75: 229-234.
16. Kotsar A, Isotalo T, Uurto I, Mikkonen J, Martikainen P, Talja M, Kellomäki M, Salenius JP, Tammela TLJ,. Urethral in situ biocompatibility of new drug-eluting biodegradable stents: An experimental study in the rabbit. BJU Int 2009; 103: 1132-1135.
17. Cutright DE, Hunsuck EE,. Tissue reaction to the biodegradable polylactic acid suture. Oral Surg Oral Med Oral Pathol 1971; 31: 134-139.
18. Rezwan K, Chen QZ, Blaker JJ, Boccaccini AR,. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006; 27: 3413-3431.
19. Mainardes RM, Silva LP,. Drug delivery systems: Past, present, and future. Curr Drug Targets 2004; 5: 449-455.
20. Mei H, Shi W, Pang Z, Wang H, Lu W, Jiang X, Deng J, Guo T, Hu Y,. EGFP-EGF1 protein-conjugated PEG-PLA nanoparticles for tissue factor targeted drug delivery. Biomaterials 2010; 31: 5619-5626.
21. Kenawy E, Abdel-Hay F, El-Newehy M, Wnek G,. Processing of polymer nanofibers through electrospinning as drug delivery systems. Mater Chem Phys 2009; 113: 296-302.
22. Cano M, Vincent B,. Controlled release of 4-nitroanisole from poly(lactic acid) nanoparticles. J Control Release 2002; 82: 127-135.
23. Bounds W, Szarewski A, Lowe D, Guillebaud J,. Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring. Eur J Obstet Gynecol Reprod Biol 1993; 48: 123-125.
24. Weisberg E, Fraser IS, Baker J, Archer D, Landgren BM, Killick S, Soutter P, Krause T, D'arcangues C,. A randomized comparison of the effects on vaginal and cervical epithelium of a placebo vaginal ring with non-use of a ring. Contraception 2000; 62: 83-89.
25. Hillier SL, Moench T, Shattock R, Black R, Reichelderfer P, Veronese F,. In vitro and in vivo: the story of nonoxynol 9. J Acquir Immune Defic Syndr 2005; 39: 1-8.
26. Xu X, Chen X, Ma P, Wang X, Jing X,. The release behaviour of doxorubicin hydrochloride from medicated fibres prepared by emulsion-electrospinning. Eur J Pharm Biopharm 2008; 70: 165-170.
27. Han J, Chen T, White C, Zhu L,. Electrospun shikonin-loaded PCL/PTMC composite fibre mats with potential biomedical applications. Int J Pharm 2009; 382: 215-221.
28. Kenawy ER, Bowlin GL, Mansfield K, Layman J, Simpson DG, Sanders EH, Wnek GH,. Release of tetracycline hydrochloride from electrospun poly(ethylene-co-vinylacetate), poly(lactic acid) and a blend. J Control Release 2002; 81: 57-64.
29. Rohan LC, Moncla BJ, Ayudhya RP, Cost M, Huang Y, Gai F, Billitto N, Lynam JD, Pryke K, Graebing P, Hopkins N, Rooney JF, Friend D, Dezzutti CS,. In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. PLoS One 2010; 5.